WILLOW (NCT05162586) is a randomized, double-blind, placebo-controlled Phase 2 proof of concept and dose-finding study designed to evaluate the efficacy and safety of enpatoran in patients with ...

Discover how butterfly rashes, purple spots, and other skin changes can reveal lupus, blood disorders, and serious diseases ...